{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:39:28Z","timestamp":1789695568921,"version":"4.0.1"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF:220005"],"award-info":[{"award-number":["IF:220005"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["220005"],"award-info":[{"award-number":["220005"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["17x(3)\/Adhoc\/33\/2022-ITR"],"award-info":[{"award-number":["17x(3)\/Adhoc\/33\/2022-ITR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EM\/Dev\/SG\/75\/0782\/2023"],"award-info":[{"award-number":["EM\/Dev\/SG\/75\/0782\/2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP43065\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP43065\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.arr.2026.103148","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:08:51Z","timestamp":1776874131000},"page":"103148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Co-aggregation of amyloidogenic proteins in age-related neurodegenerative diseases"],"prefix":"10.1016","volume":"118","author":[{"given":"Shaik","family":"Basha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakruti Prakash","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna Ramakrishna","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-3445","authenticated-orcid":false,"given":"Krishna Kishore","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103148_bib1","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/jacsau.2c00438","article-title":"Molecular Structure of Cu(II)-Bound Amyloid-\u03b2 monomer implicated in inhibition of peptide self-assembly in Alzheimer\u2019s Disease","volume":"2","author":"Abelein","year":"2022","journal-title":"JACS Au"},{"key":"10.1016\/j.arr.2026.103148_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.842582","article-title":"Linking Alzheimer\u2019s Disease and type 2 diabetes: characterization and inhibition of cytotoxic A\u03b2 and IAPP hetero-aggregates","volume":"9","author":"Al Adem","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.arr.2026.103148_bib3","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1080\/07391102.2023.2293258","article-title":"Comprehensive mapping of mutations in TDP-43 and \u03b1-Synuclein that affect stability and binding","volume":"43","author":"Alamri","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2026.103148_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijms.2016.09.018","article-title":"1,2,3,4,6-penta-O-galloyl-\u03b2-d-glucopyranose binds to the N-terminal metal binding region to inhibit amyloid \u03b2-protein oligomer and fibril formation","volume":"420","author":"de Almeida","year":"2017","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.arr.2026.103148_bib5","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the A\u03b2\u2013IAPP interaction interface as high-affinity binding sites in both cross- and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.arr.2026.103148_bib6","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.3390\/ijms22168556","article-title":"Co-Aggregation of S100A9 with DOPA and cyclen-based compounds manifested in amyloid fibril thickening without altering rates of self-assembly","volume":"22","author":"Arabuli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/\u03b1-synuclein-epitopes in Lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2026.103148_bib8","doi-asserted-by":"crossref","first-page":"524a","DOI":"10.1016\/j.bpj.2014.11.2872","article-title":"Co-aggregation of alpha-synuclein with amylin(HIAPP) leads to an increased risk in type ii diabetes patients for developing Parkinson\u2019s Disease","volume":"108","author":"Atsmon-Raz","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2026.103148_bib9","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/ncomms5755","article-title":"Glucocerebrosidase depletion enhances cell-to-cell transmission of \u03b1-synuclein","volume":"5","author":"Bae","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib10","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1039\/D1SC01122G","article-title":"Quantitative interrogation of protein co-aggregation using multi-color fluorogenic protein aggregation sensors","volume":"12","author":"Bai","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2026.107307","article-title":"Artificial intelligence and machine learning in neurodegenerative disease management: A 21st century paradigm","volume":"220","author":"Basha","year":"2026","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2025.105390","article-title":"Citrus phytochemicals in neurodegenerative diseases: preclinical evidence and clinical potential","volume":"166","author":"Basha","year":"2025","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.arr.2026.103148_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143725","article-title":"Assessing amyloid fibrils and amorphous aggregates: a review","volume":"311","author":"Basha","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103148_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102017","article-title":"A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies","volume":"90","author":"Basha","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103148_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-Beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103148_bib16","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192193","article-title":"\u03b1-Synuclein modulates tau spreading in mouse brains","volume":"218","author":"Bassil","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2026.103148_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-025-01767-x","article-title":"Protein co-aggregates of dense core amyloid plaques and CSF differ in rapidly progressive Alzheimer\u2019s disease and slower sporadic Alzheimer\u2019s disease","volume":"17","author":"Bebek","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103148_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800059","article-title":"Formation of heterotypic amyloids: \u03b1-synuclein in co-aggregation","volume":"18","author":"Bhasne","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.arr.2026.103148_bib19","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.jmb.2018.04.020","article-title":"Synergistic amyloid switch triggered by early heterotypic oligomerization of intrinsically disordered \u03b1-synuclein and Tau","volume":"430","author":"Bhasne","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib20","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3390\/ijms19082292","article-title":"Protein co-aggregation related to amyloids: methods of investigation, diversity, and classification","volume":"19","author":"Bondarev","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/13506129.2012.762761","article-title":"IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta- O -galloyl-\u03b2-D-glucose","volume":"20","author":"Bruno","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.arr.2026.103148_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/toxics10100559","volume":"10","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.arr.2026.103148_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00382","article-title":"Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson Disease","volume":"13","author":"Canerina-Amaro","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109120","article-title":"\u03b1-synuclein-assisted oligomerization of \u03b2-amyloid (1\u201342)","volume":"717","author":"Chau","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.arr.2026.103148_bib25","doi-asserted-by":"crossref","first-page":"9646","DOI":"10.1074\/jbc.M110.177246","article-title":"Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-\u03b2 stability, oligomerization, and aggregation","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib26","article-title":"Unraveling the interplay of \u03b2-amyloid pathology and Parkinson\u2019s disease progression: insights from autopsy-confirmed patients","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2026.103148_bib27","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1073\/pnas.1700239114","article-title":"Monomeric and fibrillar \u03b1-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of A\u03b242 aggregates","volume":"114","author":"Chia","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/brain\/awad388","article-title":"Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease","volume":"147","author":"Chu","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103148_bib29","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/brain\/awae372","article-title":"Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer\u2019s disease and synucleinopathies","volume":"148","author":"Colloby","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103148_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.01.001","article-title":"A\u03b2 puts the alpha in synuclein","volume":"105","author":"Cook","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103148_bib31","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1074\/jbc.M112.436006","article-title":"Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation","volume":"288","author":"Crowe","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib32","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau interacts with the c-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations","volume":"58","author":"Dasari","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2026.103148_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2017.04.012","article-title":"TDP-43 expression influences amyloid\u03b2 plaque deposition and Tau aggregation","volume":"103","author":"Davis","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00401-023-02657-y","article-title":"Distinct tau and alpha-synuclein molecular signatures in Alzheimer\u2019s disease with and without Lewy bodies and Parkinson\u2019s disease with dementia","volume":"147","author":"van der Gaag","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103148_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102566","article-title":"Molecular mechanisms of neurofilament alterations and its application in assessing neurodegenerative disorders","volume":"102","author":"Devarakonda","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103148_bib36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s42003-023-05608-1","article-title":"\u03b1-Synuclein emulsifies TDP-43 prion-like domain\u2014RNA liquid droplets to promote heterotypic amyloid fibrils","volume":"6","author":"Dhakal","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102498","article-title":"Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with \u03b1-Synuclein","volume":"298","author":"Dhakal","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166953","article-title":"Prion-like C-terminal domain of TDP-43 and \u03b1-synuclein interact synergistically to generate neurotoxic hybrid fibrils","volume":"433","author":"Dhakal","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib39","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.1074\/jbc.M109.080390","article-title":"Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of \u03b1-synuclein and \u03b2-amyloid and protect against amyloid-induced toxicity","volume":"285","author":"Di Giovanni","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib40","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0165","article-title":"Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer\u2019s disease peptide \u03b2-amyloid (1\u201342)","volume":"11","author":"Everett","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.arr.2026.103148_bib41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2353\/ajpath.2008.070829","article-title":"Co-Localization of amyloid beta and tau pathology in Alzheimer\u2019s disease synaptosomes","volume":"172","author":"Fein","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2026.103148_bib42","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.1002\/alz.14250","article-title":"A framework for translating tauopathy therapeutics: drug discovery to clinical trials","volume":"20","author":"Feldman","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2026.103148_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10654-013-9864-1","article-title":"Evidence for modest familial co-aggregation between dementia and parkinsonism","volume":"29","author":"Feldman","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.arr.2026.103148_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-024-01913-w","article-title":"Distinct subcellular localization of tau and alpha-synuclein in lewy body disease","volume":"13","author":"Fischer","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107548","article-title":"Tau and \u0251-synucleinopathy co-pathology in military veterans with parkinsonism: an autopsy study","volume":"134","author":"Flores Almazan","year":"2025","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2026.103148_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069242","article-title":"p53 aggregates penetrate cells and induce the co-aggregation of intracellular p53","volume":"8","author":"Forget","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103148_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-025-00822-3","article-title":"Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer\u2019s disease","volume":"20","author":"Franzmeier","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib48","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1021\/acschemneuro.0c00281","article-title":"Dual targeting of monomeric tau and \u03b1-synuclein aggregation: a new multitarget therapeutic strategy for neurodegeneration","volume":"11","author":"Gabr","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0304-3940(89)90651-4","article-title":"The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease","volume":"100","author":"Galloway","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2026.103148_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165580","article-title":"TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer\u2019s disease","volume":"1866","author":"Gao","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.arr.2026.103148_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622764","article-title":"Transient lipid-protein structures and selective ganglioside uptake during \u03b1-synuclein-lipid co-aggregation","volume":"9","author":"Gaspar","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib52","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/acschemneuro.4c00334","article-title":"TDP-43 promotes amyloid-beta toxicity by delaying fibril maturation via direct molecular interaction","volume":"15","author":"Gatch","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib53","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/acschemneuro.5c00084","article-title":"Cross-interaction with amyloid-\u03b2 drives pathogenic structural transformation within the amyloidogenic core region of TDP-43","volume":"16","author":"Gatch","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-025-01538-2","article-title":"Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities","author":"Ge","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2026.103148_bib55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.neuint.2007.10.020","article-title":"Amyloid-\u03b2 peptide binds to microtubule-associated protein 1B (MAP1B)","volume":"52","author":"Gevorkian","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2026.103148_bib56","first-page":"636","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science (1979)"},{"key":"10.1016\/j.arr.2026.103148_bib57","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bbrc.2005.06.025","article-title":"Single particle detection and characterization of synuclein co-aggregation","volume":"333","author":"Giese","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103148_bib59","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1021\/acsomega.9b03497","article-title":"Amyloid-\u03b2-derived peptidomimetics inhibits Tau aggregation","volume":"6","author":"Gorantla","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2026.103148_bib60","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1038\/s41467-022-32350-9","article-title":"Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau","volume":"13","author":"Gracia","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46924","article-title":"Structure-based inhibitors of amyloid beta core suggest a common interface with tau","volume":"8","author":"Griner","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.arr.2026.103148_bib62","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ncl.2024.12.013","article-title":"Experimental therapeutics in Parkinson\u2019s Disease","volume":"43","author":"Gros","year":"2025","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.arr.2026.103148_bib63","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1093\/nar\/gkx175","article-title":"TDP-43 suppresses tau expression via promoting its mRNA instability","volume":"45","author":"Gu","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2026.103148_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103148_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.623659","article-title":"Targeted quantification of detergent-insoluble RNA-binding proteins in human brain reveals stage and disease specific co-aggregation in Alzheimer\u2019s Disease","volume":"14","author":"Guo","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145500","article-title":"cis and trans isomers of phospho-tau proteins differently affect amyloid aggregation","volume":"320","author":"Hajipour","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103148_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00045","article-title":"Proteostasis of \u03b1-synuclein and its role in the pathogenesis of Parkinson\u2019s disease","volume":"14","author":"Han","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077235","article-title":"Membrane lipid co-aggregation with \u03b1-synuclein fibrils","volume":"8","author":"Hellstrand","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103148_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.febslet.2011.11.019","article-title":"\u03b1-Synuclein modifies huntingtin aggregation in living cells","volume":"586","author":"Herrera","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2026.103148_bib70","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4103\/1673-5374.300983","article-title":"TDP-43 and amyloid precursor protein processing: implications for Alzheimer\u2019s disease","volume":"16","author":"Hicks","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2026.103148_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","article-title":"Concurrence of TDP-43, tau and \u03b1-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"1184","author":"Higashi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2026.103148_bib72","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12974-018-1210-9","article-title":"Co-aggregation of pro-inflammatory S100A9 with \u03b1-synuclein in Parkinson\u2019s disease: ex vivo and in vitro studies","volume":"15","author":"Horvath","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2026.103148_bib73","doi-asserted-by":"crossref","unstructured":"Horvath, I., Rocha, S., Wittung-Stafshede, P., 2018b. In Vitro Analysis of \u03b1-Synuclein Amyloid Formation and Cross-Reactivity. pp. 73\u201383. https:\/\/doi.org\/10.1007\/978-1-4939-7816-8_6.","DOI":"10.1007\/978-1-4939-7816-8_6"},{"key":"10.1016\/j.arr.2026.103148_bib74","doi-asserted-by":"crossref","first-page":"31604","DOI":"10.1039\/D3CP04138G","article-title":"Co-aggregation of \u03b1-synuclein with amyloid-\u03b2 stabilizes \u03b2-sheet-rich oligomers and enhances the formation of \u03b2-barrels","volume":"25","author":"Huang","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.arr.2026.103148_bib75","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","article-title":"A\u03b2 Accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer Mouse Model","volume":"177","author":"Hurtado","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2026.103148_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300320","article-title":"A RaPID macrocyclic peptide that inhibits the formation of \u03b1-synuclein amyloid fibrils","volume":"24","author":"Ikenoue","year":"2023","journal-title":"ChemBioChem"},{"key":"10.1016\/j.arr.2026.103148_bib77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","article-title":"Colocalization of Tau and alpha-synuclein epitopes in lewy bodies","volume":"62","author":"Ishizawa","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103148_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-022-00289-y","article-title":"Pathophysiological significance of increased \u03b1-synuclein deposition in sympathetic nerves in Parkinson\u2019s disease: a post-mortem observational study","volume":"11","author":"Isonaka","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106507","article-title":"Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology","volume":"269","author":"Ivanova","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib80","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in lewy body disorders","volume":"08","author":"Irwin","year":"2018","journal-title":"J. Alzheimers Dis. Park."},{"key":"10.1016\/j.arr.2026.103148_bib81","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.arr.2026.103148_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.50","article-title":"A natural BACE1 and GSK3\u03b2 dual inhibitor Notopterol effectively ameliorates the cognitive deficits in APP\/PS1 Alzheimer\u2019s mice by attenuating amyloid-\u03b2 and tau pathology","volume":"10","author":"Jiang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.arr.2026.103148_bib83","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.3390\/ijms252212380","article-title":"Co-aggregation of TDP-43 with other pathogenic proteins and their co-pathologies in neurodegenerative diseases","volume":"25","author":"Jiang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib84","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1038\/s41598-019-40483-z","article-title":"Conservation of the amyloid interactome across diverse fibrillar structures","volume":"9","author":"Juhl","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103148_bib85","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/05704928.2025.2477237","article-title":"Fluorescence in probing the biochemical and conformational changes in non-enzymatically glycated proteins","volume":"60","author":"K","year":"2025","journal-title":"Appl. Spectrosc. Rev."},{"key":"10.1016\/j.arr.2026.103148_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.148461","article-title":"Emerging insights of fibrinogen glycation in cardiovascular disorders: a review","volume":"331","author":"K","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103148_bib87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcdb.2023.08.002","article-title":"Proteotoxic stress and the ubiquitin proteasome system","volume":"156","author":"Kandel","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134564","volume":"715","author":"Katayama","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2026.103148_bib89","doi-asserted-by":"crossref","first-page":"11241","DOI":"10.3390\/ijms241411241","article-title":"Molecular mechanism of zinc-dependent oligomerization of Alzheimer\u2019s amyloid-\u03b2 with Taiwan (D7H) Mutation","volume":"24","author":"Kechko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/09727531221136349","article-title":"Future of monoclonal antibody therapy in Parkinson\u2019s Disease","volume":"30","author":"Kharel","year":"2023","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib91","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/mdc3.13235","article-title":"Neuropathology of perry syndrome: evidence of medullary and hypothalamic involvement","volume":"8","author":"Kim","year":"2021","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.arr.2026.103148_bib92","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.3390\/ijms22147697","article-title":"Redox-active metal ions and amyloid-degrading enzymes in Alzheimer\u2019s Disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib93","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-beta peptides trigger aggregation of alpha-synuclein in vitro","volume":"25","author":"K\u00f6ppen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2026.103148_bib94","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bpa.12890","article-title":"RAB39B is redistributed in dementia with Lewy bodies and is sequestered within a\u03b2 plaques and Lewy bodies","volume":"31","author":"Koss","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2026.103148_bib95","doi-asserted-by":"crossref","first-page":"25929","DOI":"10.1039\/D0RA04949B","article-title":"Bleomycin modulates amyloid aggregation in \u03b2-amyloid and hIAPP","volume":"10","author":"Kumari","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.arr.2026.103148_bib96","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s13311-020-00853-2","article-title":"Immunotherapies for aging-related neurodegenerative diseases\u2014emerging perspectives and new targets","volume":"17","author":"Kwon","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2026.103148_bib97","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s11357-021-00407-0","article-title":"Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer\u2019s disease","volume":"43","author":"Latimer","year":"2021","journal-title":"Geroscience"},{"key":"10.1016\/j.arr.2026.103148_bib98","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.ccr.2012.04.004","article-title":"Metal ions as modulators of protein conformation and misfolding in neurodegeneration","volume":"256","author":"Leal","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.arr.2026.103148_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","article-title":"Targeted degradation of \u237a-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology","volume":"18","author":"Lee","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00457","article-title":"Dysfunction of cellular proteostasis in Parkinson\u2019s Disease","volume":"13","author":"Lehtonen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127841","article-title":"Structural insights into the co-aggregation of A\u03b2 and tau amyloid core peptides: revealing potential pathological heterooligomers by simulations","volume":"254","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103148_bib102","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-024-05383-0","article-title":"Novel C. elegans models of Lewy body disease reveal pathological protein interactions and widespread miRNA dysregulation","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.arr.2026.103148_bib103","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1021\/acs.jpcb.0c11132","article-title":"Mechanistic insights into the co-aggregation of A\u03b2 and hIAPP: an all-atom molecular dynamic study","volume":"125","author":"Li","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.arr.2026.103148_bib104","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.3390\/molecules27238383","article-title":"Modulation Effects of Fe3+, Zn2+, and Cu2+ ions on the amyloid fibrillation of \u03b1-synuclein: insights from a FTIR investigation","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2026.103148_bib105","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3390\/ijms25031636","article-title":"The inhibition effect of epigallocatechin-3-gallate on the co-aggregation of Amyloid-\u03b2 and human islet amyloid polypeptide revealed by replica exchange molecular dynamics simulations","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib106","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/A\u03b242 predict cognitive decline in Parkinson\u2019s disease","volume":"21","author":"Liu","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2026.103148_bib107","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/CLEP.S164330","article-title":"Familial aggregation of Parkinson\u2019s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study","volume":"10","author":"Liu","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.arr.2026.103148_bib108","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1074\/jbc.RA119.012284","article-title":"Structural basis of the interplay between \u03b1-synuclein and Tau in regulating pathological amyloid aggregation","volume":"295","author":"Lu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02021","article-title":"Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here?","volume":"11","author":"Mallah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103148_bib110","doi-asserted-by":"crossref","first-page":"24426","DOI":"10.1021\/jacs.4c06372","article-title":"Single-molecule characterization of heterogeneous oligomer formation during Co-aggregation of 40- and 42-residue amyloid-\u03b2","volume":"146","author":"Meng","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2026.103148_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168499","article-title":"The \u03b1-crystallin chaperones undergo a quasi-ordered co-aggregation process in response to saturating client interaction","volume":"436","author":"Miller","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105130","article-title":"TDP-43 and Tau oligomers in Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia","volume":"146","author":"Montalbano","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib113","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","article-title":"Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer\u2019s disease: a comprehensive review of the characteristics and therapeutic strategies","volume":"14","author":"Nam","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib114","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2147\/DDDT.S289473","article-title":"Epigallocatechin-3-gallate provides protection against Alzheimer\u2019s disease-induced learning and memory impairments in rats","volume":"15","author":"Nan","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.arr.2026.103148_bib115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-\u03b2","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103148_bib116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-7-35","article-title":"Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with \u03b1-synuclein at the single molecule level","volume":"7","author":"N\u00fcbling","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib117","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-161017","article-title":"PE859, A novel curcumin derivative, inhibits amyloid-\u03b2 and tau aggregation, and ameliorates cognitive dysfunction in senescence-accelerated mouse Prone 8","volume":"59","author":"Okuda","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2023.140943","article-title":"Antibodies and \u03b1-synuclein: what to target against Parkinson\u2019s Disease?","volume":"1872","author":"Otzen","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Proteins Proteom."},{"key":"10.1016\/j.arr.2026.103148_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s Disease in 204 Countries\/Territories From 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.arr.2026.103148_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1570553","article-title":"\u03b1-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies","volume":"19","author":"Padilla-God\u00ednez","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib121","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","article-title":"Tau in the pathophysiology of Parkinson\u2019s disease","volume":"71","author":"Pan","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib122","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1021\/acschemneuro.1c00235","article-title":"Dual Inhibitors of amyloid-\u03b2 and tau aggregation with amyloid-\u03b2 disaggregating properties: extended In Cellulo, In Silico, and kinetic studies of multifunctional anti-Alzheimer\u2019s Agents","volume":"12","author":"Pasieka","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib123","article-title":"From pathogenesis to precision medicine: targeting immune imbalance in multiple sclerosis","author":"Pithakumar","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103148_bib124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/C9RA09350H","article-title":"Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations","volume":"10","author":"Poulson","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.arr.2026.103148_bib125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","article-title":"Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib126","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/acschemneuro.8b00039","article-title":"Genistein: a dual inhibitor of both amyloid \u03b2 and human islet amylin peptides","volume":"9","author":"Ren","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib127","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1039\/C9TB01871A","article-title":"Fundamentals of cross-seeding of amyloid proteins: an introduction","volume":"7","author":"Ren","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.arr.2026.103148_bib128","doi-asserted-by":"crossref","first-page":"15755","DOI":"10.3390\/ijms232415755","article-title":"TDP-43 proteinopathy and tauopathy: do they have pathomechanistic links?","volume":"23","author":"Riku","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib129","article-title":"Amyloid-\u03b2 modulates the phase separation and aggregation of \u03b1-synuclein","volume":"122","author":"R\u00f6ntgen","year":"2025"},{"key":"10.1016\/j.arr.2026.103148_bib130","article-title":"Modulation of \u03b1-synuclein in vitro aggregation kinetics by its alternative splice isoforms","volume":"121","author":"R\u00f6ntgen","year":"2024"},{"key":"10.1016\/j.arr.2026.103148_bib131","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/emboj.2009.298","article-title":"Chaperone proteostasis in Parkinson\u2019s disease: stabilization of the Hsp70\/\u03b1-synuclein complex by Hip","volume":"28","author":"Roodveldt","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2026.103148_bib132","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-023-00621-8","article-title":"Mutations in \u03b1-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases","volume":"18","author":"Sampognaro","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib133","first-page":"S189","article-title":"Gene therapy to modulate alpha-synuclein in synucleinopathies","volume":"11","author":"Sandoval","year":"2021","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib134","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.bbadis.2018.06.020","article-title":"Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified \u03b1-synuclein oligomers","volume":"1864","author":"Sardar Sinha","year":"2018","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.arr.2026.103148_bib135","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103148_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144651","article-title":"Cross-talk between amyloid beta peptides and tau proteins in Co-aggregation investigating with the combination of coarse-grained and all-atom simulations","volume":"316","author":"Shang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2026.103148_bib137","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","article-title":"TDP-43 interacts with amyloid-\u03b2, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease","volume":"11","author":"Shih","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/srep37630","article-title":"Nanomolar oligomerization and selective co-aggregation of \u03b1-synuclein pathogenic mutants revealed by single-molecule fluorescence","volume":"6","author":"Sierecki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103148_bib139","series-title":"Direct binding of TDP-43 and Tau drives their co-condensation, but suppresses Tau fibril formation and seeding","author":"Simonetti","year":"2025"},{"key":"10.1016\/j.arr.2026.103148_bib140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bpa.12505","article-title":"Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi","volume":"28","author":"Smith","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2026.103148_bib141","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3233\/JAD-181001","article-title":"Methylene blue inhibits formation of tau fibrils but not of granular tau oligomers: a plausible key to understanding failure of a clinical trial for Alzheimer\u2019s Disease","volume":"68","author":"Soeda","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103148_bib142","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103148_bib143","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/molecules27061776","article-title":"Amyloid cross-seeding: mechanism, implication, and inhibition","volume":"27","author":"Subedi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2026.103148_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00512","article-title":"Inducers and modulators of protein aggregation in Alzheimer\u2019s disease - critical tools for understanding the foundations of aggregate structures","volume":"22","author":"Sun","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2026.103148_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108351","article-title":"Structural basis of a distinct \u03b1-synuclein strain that promotes tau inclusion in neurons","volume":"301","author":"Sun","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103148_bib146","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41467-024-45692-3","article-title":"Reduced progranulin increases tau and \u03b1-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase","volume":"15","author":"Takahashi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib147","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.29273","article-title":"In vivo 18 F-Florzolotau tau positron emission tomography imaging in Parkinson\u2019s Disease dementia","volume":"38","author":"Tang","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103148_bib148","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pro.4247","article-title":"A new strategy to reconcile amyloid cross-seeding and amyloid prevention in a binary system of \u03b1-synuclein fragmental peptide and hIAPP","volume":"31","author":"Tang","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.arr.2026.103148_bib149","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1038\/s41467-022-32688-0","article-title":"Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly","volume":"13","author":"Ta\u015f","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib150","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/acsomega.4c09114","article-title":"Evolving landscape of Parkinson\u2019s disease research: challenges and perspectives","volume":"10","author":"Tenchov","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2026.103148_bib151","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103148_bib152","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-021-02295-2","article-title":"TDP-43 interacts with pathological \u03c4 protein in Alzheimer\u2019s disease","volume":"141","author":"Tom\u00e9","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103148_bib153","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-023-00653-0","article-title":"TDP-43 pathology is associated with increased tau burdens and seeding","volume":"18","author":"Tom\u00e9","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib154","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/acs.biochem.9b01087","article-title":"Direct Interaction between the \u03b2-amyloid core and tau facilitates cross-seeding: a novel target for therapeutic intervention","volume":"59","author":"Tripathi","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2026.103148_bib155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103148_bib156","doi-asserted-by":"crossref","first-page":"18276","DOI":"10.1021\/jacs.3c03212","article-title":"\u03b1-synuclein aggregation is triggered by oligomeric amyloid-\u03b2 42 via heterogeneous primary nucleation","volume":"145","author":"Vadukul","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2026.103148_bib157","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1021\/jacs.7b13623","article-title":"The neuronal tau protein blocks in vitro fibrillation of the amyloid-\u03b2 (A\u03b2) peptide at the oligomeric stage","volume":"140","author":"Wallin","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2026.103148_bib158","article-title":"Prevalence of mixed neuropathologies in age-related neurodegenerative diseases: a community-based autopsy study in China","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2026.103148_bib159","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2019.01.008","article-title":"The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals","volume":"77","author":"Wennberg","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103148_bib160","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa090","article-title":"Differential cross-seeding properties of tau and \u03b1-synuclein in mouse models of tauopathy and synucleinopathy","volume":"2","author":"Williams","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103148_bib161","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jmb.2018.05.024","article-title":"Multi-pronged interactions underlie inhibition of \u03b1-synuclein aggregation by \u03b2-synuclein","volume":"430","author":"Williams","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2026.103148_bib162","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","article-title":"Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia","volume":"225","author":"Wills","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103148_bib163","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","article-title":"Associations between Tau, \u03b2-Amyloid, and cognition in Parkinson Disease","volume":"75","author":"Winer","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103148_bib164","article-title":"Identifying the role of co-aggregation of Alzheimer\u2019s amyloid-\u03b2 with amorphous protein aggregates of non-amyloid proteins","volume":"3","author":"Wu","year":"2022","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.arr.2026.103148_bib165","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-024-49028-z","article-title":"Co-aggregation with Apolipoprotein E modulates the function of Amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"15","author":"Xia","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103148_bib166","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.29048","article-title":"TDP-43 proteinopathy presenting with typical symptoms of Parkinson\u2019s Disease","volume":"37","author":"Yamashita","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103148_bib167","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/15548627.2022.2083857","article-title":"A prion-like domain of TFEB mediates the co-aggregation of TFEB and mHTT","volume":"19","author":"Yang","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2026.103148_bib168","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41420-025-02340-z","article-title":"TDP43 is a newly identified substrate for PS1, enhancing the expression of APP following cleavage","volume":"11","author":"Yin","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.arr.2026.103148_bib169","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","article-title":"Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease","volume":"28","author":"Yuan","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103148_bib170","article-title":"Tau-PET imaging in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103148_bib171","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.7150\/thno.112396","article-title":"Unraveling \u03b1-synuclein and amylin co-aggregation: pathological insights and biomarker development for Parkinson\u2019s disease","volume":"15","author":"Zhou","year":"2025","journal-title":"Theranostics"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:04:31Z","timestamp":1786017871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":171,"alternative-id":["S1568163726001406"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103148","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-aggregation of amyloidogenic proteins in age-related neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103148"}}